GDMECC0024DB · 5 Orthopedic Prosthetics Market Pipeline Products ... Orthopedic Devices Market, by Country ... Medical Equipment Market Reports are the ideal guide for anyone wishing

United Kingdom Orthopedic Prosthetics Market Outlook to 2020 GDMECC0024DB / Published February 2014

© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form

Page 1

United Kingdom Orthopedic

Prosthetics Market Outlook to 2020

Reference Code: GDMECC0024DB

Publication Date: February 2014

SAMPLE



Page 2

1 Table of Contents

1 Table of Contents .................................................................................................................................................... 2

1.1 List of Tables .................................................................................................................................................... 3

1.2 List of Figures ................................................................................................................................................... 3

2 Introduction .............................................................................................................................................................. 4

2.1 What Is This Report About? ............................................................................................................................. 4

2.2 Orthopedic Prosthetics Market Segmentation ................................................................................................. 4

2.3 Definitions of Markets Covered in the Report .................................................................................................. 5

3 Orthopedic Prosthetics Market, United Kingdom ................................................................................................ 6

3.1 Orthopedic Prosthetics Market, United Kingdom, Revenue ($m), 2005-2012 ................................................. 6

3.2 Orthopedic Prosthetics Market, United Kingdom, Revenue ($m), 2012-2020 ................................................. 7

3.3 Orthopedic Prosthetics Market, United Kingdom, Volume (Units), 2005-2012 ................................................ 9

3.4 Orthopedic Prosthetics Market, United Kingdom, Volume (Units), 2012-2020 .............................................. 11

3.5 Orthopedic Prosthetics Market, United Kingdom, Average Price ($), 2005-2020 ......................................... 13

3.6 Orthopedic Prosthetics Market, United Kingdom, Distribution Share by Revenue ($m), 2011-2012 ............ 14

3.7 Orthopedic Prosthetics Market, United Kingdom, Company Share by Revenue ($m), 2011-2012 ............... 15

4 Overview of Key Companies in United Kingdom Orthopedic Prosthetics Market ......................................... 16

4.1 Otto Bock HealthCare GmbH ......................................................................................................................... 16

4.1.1 Company Overview .................................................................................................................................... 16

4.2 Ossur hf. ......................................................................................................................................................... 16


4.3 The Ohio Willow Wood Company .................................................................................................................. 16


4.4 Touch Bionics Limited .................................................................................................................................... 17


5 Orthopedic Prosthetics Market Pipeline Products ............................................................................................. 18

6 Financial Deals Landscape ................................................................................................................................... 19

6.1 Partnerships ................................................................................................................................................... 19

6.1.1 Ergoresearch Enters Into Distribution Agreement With Proteor For Orthopedic Components .................. 19

7 Recent Developments ........................................................................................................................................... 21

7.1 Product News ................................................................................................................................................. 21

7.1.1 Jul 08, 2013: Southampton engineers develop novel method to increase lifespan of joint replacements 21

8 Appendix ................................................................................................................................................................ 22

8.1 Research Methodology ...................................................................................................................................... 23

8.1.1 Coverage ...................................................................................................................................................... 23

8.1.2 Secondary Research .................................................................................................................................... 23

8.1.3 Primary Research ......................................................................................................................................... 24

7.1.4 Market Modeling and Forecasting ................................................................................................................ 25

8.1.5 Company Share Analysis ............................................................................................................................. 28

8.1.6 Distribution Share Analysis ........................................................................................................................... 29

SAMPLE



Page 3

8.2 Expert Panels ..................................................................................................................................................... 29

8.3 GlobalData Consulting ....................................................................................................................................... 30

8.5 Disclaimer .......................................................................................................................................................... 30

1.1 List of Tables

Table 1: Orthopedic Prosthetics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012 .............................. 6

Table 2: Orthopedic Prosthetics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020 ............................ 8

Table 3: Orthopedic Prosthetics Market, United Kingdom, Volume (Units), Historic, 2005-2012 ................................................... 10

Table 4: Orthopedic Prosthetics Market, United Kingdom, Volume (Units), Forecast, 2012-2020 ................................................. 12

Table 5: Orthopedic Prosthetics Market, United Kingdom, Average Price ($), Historic, 2005-2012 ............................................... 13

Table 6: Orthopedic Prosthetics Market, United Kingdom, Average Price ($), Forecast, 2012-2020 ............................................. 13

Table 7: Orthopedic Prosthetics Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ....... 14

Table 8: Orthopedic Prosthetics Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2011-2012 .......... 15

Table 9: Orthopedic Prosthetics Market Pipeline Products............................................................................................................. 18

Table 10: Ergoresearch Enters Into Distribution Agreement With Proteor For Orthopedic Components ....................................... 19

Table 11: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country ............................................ 25

1.2 List of Figures

Figure 1: Orthopedic Prosthetics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012 ............................ 6

Figure 2: Orthopedic Prosthetics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020 .......................... 7

Figure 3: Orthopedic Prosthetics Market, United Kingdom, Volume (Units), Historic, 2005-2012 .................................................... 9

Figure 4: Orthopedic Prosthetics Market, United Kingdom, Volume (Units), Forecast, 2012-2020 ................................................ 11

Figure 5: Orthopedic Prosthetics Market, United Kingdom, Company Share (%), 2012 ................................................................ 15

Figure 6: GlobalData Epidemiology Based Forecasting Model ...................................................................................................... 27

Figure 7: GlobalData Capital Equipment Based Forecasting Model ............................................................................................... 28

Figure 8: Primary Calls Split by Participants ................................................................................................................................... 29

SAMPLE



Page 4

2 Introduction

Medical Equipment Market Reports are the ideal guide for anyone wishing to understand their market better in terms

of revenues, unit sales, distributors and competitors.

2.1 What Is This Report About?

This report provides an overview and the following information related to the country, various categories, distribution

share and competitive landscape in the market:

1. Comprehensive data related to the market revenue, unit sale, average price, company share and distribution

share.

2. Corporate-level profiles of key companies operating in the Orthopedic Prosthetics market, which includes a

brief overview of the company. The selection of the companies is based on their operational presence.

3. A list of key products under development by different companies. The selection of this list is based on the

territory in which these products are being clinically investigated.

4. Key news and deals related to the Orthopedic Prosthetics market.

2.2 Orthopedic Prosthetics Market Segmentation

Orthopedic Prosthetics market is segmented into the following categories, as described below, in this report:

1. Lower Extremity Prosthetics

2. Upper Extremity Prosthetics

SAMPLE



Page 5

2.3 Definitions of Markets Covered in the Report

Orthopedic Prosthetics

Orthopedic prosthetic is an artificial mechanical device, which is used as a substitute for a missing body part or limb.

These prostheses can be passive, conventional/body powered, electrically powered, myo-electric and hybrid.

Lower Extremity Prosthetics

Prosthetics that are designed to replace missing lower extremities (such as transfemoral, transtibial, symes, partial

and complete foot and so on) of the human body are included in lower extremity prosthetics. One unit is one

prosthetic.

Upper Extremity Prosthetics

Prosthesis that is designed to replace missing upper extremities (such as below elbow, above elbow, wrist) of the

human body are included in upper extremity prosthetics. One unit is one prosthetic.

SAMPLE



Page 6

3 Orthopedic Prosthetics Market, United Kingdom

3.1 Orthopedic Prosthetics Market, United Kingdom, Revenue ($m), 2005-2012

Figure 1: Orthopedic Prosthetics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012

Source: GlobalData

Table 1: Orthopedic Prosthetics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012

Category 2005 2006 2007 2008 2009 2010 2011 2012 CAGR 05-12

Source: GlobalData

SAMPLE



Page 7

3.2 Orthopedic Prosthetics Market, United Kingdom, Revenue ($m), 2012-2020

Figure 2: Orthopedic Prosthetics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020

Source: GlobalData

SAMPLE



Page 8

Table 2: Orthopedic Prosthetics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020

Category 2012 2013 2014 2015 2016 2017 2018 2019 2020 CAGR 12-20

Source: GlobalData

SAMPLE



Page 9

3.3 Orthopedic Prosthetics Market, United Kingdom, Volume (Units), 2005-2012

Figure 3: Orthopedic Prosthetics Market, United Kingdom, Volume (Units), Historic, 2005-2012

Source: GlobalData

SAMPLE



Page 10

Table 3: Orthopedic Prosthetics Market, United Kingdom, Volume (Units), Historic, 2005-2012

Category 2005 2006 2007 2008 2009 2010 2011 2012 CAGR 05-12

Lower Extremity Prosthetics 5,000 4,828 5,102 5,423 5,600 5,804 5,700 5,835 2.2%

% Growth -3.4% 5.7% 6.3% 3.3% 3.6% -1.8% 2.4%

Upper Extremity Prosthetics 98 111 112 117 113 124 126 132 4.3%

% Growth 13.3% 0.9% 4.5% -3.4% 9.7% 1.6% 4.8%

Total 5,098 4,939 5,214 5,540 5,713 5,928 5,826 5,967 2.3%

% Growth -3.1% 5.6% 6.3% 3.1% 3.8% -1.7% 2.4%

Source: GlobalData

The number of Orthopedic Prosthetics units sold grew from 5,098 in 2005 to reach 5,967 units in 2012 with a CAGR

of 2.3%.

SAMPLE



Page 11

3.4 Orthopedic Prosthetics Market, United Kingdom, Volume (Units), 2012-2020

Figure 4: Orthopedic Prosthetics Market, United Kingdom, Volume (Units), Forecast, 2012-2020

Source: GlobalData

SAMPLE



Page 12

Table 4: Orthopedic Prosthetics Market, United Kingdom, Volume (Units), Forecast, 2012-2020

Category 2012 2013 2014 2015 2016 2017 2018 2019 2020 CAGR 12-20

Lower Extremity Prosthetics 5,835 5,972 6,115 6,262 6,414 6,572 6,735 6,904 7,080 2.4%

% Growth 2.3% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5%

Upper Extremity Prosthetics 132 138 144 151 158 166 174 183 193 4.9%

% Growth 4.5% 4.3% 4.9% 4.6% 5.1% 4.8% 5.2% 5.5%

Total 5,967 6,110 6,259 6,413 6,572 6,738 6,909 7,087 7,273 2.5%

% Growth 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.6% 2.6%

Source: GlobalData

The sales of Orthopedic Prosthetics units are expected to grow from 5,967 in 2012 to 7,273 units in 2020 with a

CAGR of 2.5%.

SAMPLE



Page 13

3.5 Orthopedic Prosthetics Market, United Kingdom, Average Price ($), 2005-2020

Table 5: Orthopedic Prosthetics Market, United Kingdom, Average Price ($), Historic, 2005-2012

Category 2005 2006 2007 2008 2009 2010 2011 2012 CAGR

Lower Extremity Prosthetics 6,790.4 6,926.2 7,064.7 7,206.0 7,350.1 7,497.1 7,647.1 7,800.0 2.0%

% Growth 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0%

Upper Extremity Prosthetics 5,745.7 5,860.6 5,977.8 6,097.4 6,219.3 6,343.7 6,470.6 6,600.0 2.0%

% Growth 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0%

Source: GlobalData

Lower Extremity Prosthetics unit ASP increased from $6,790.4 in 2005 to $7,800.0 in 2012 with a CAGR of 2.0%.

Table 6: Orthopedic Prosthetics Market, United Kingdom, Average Price ($), Forecast, 2012-2020

Category 2012 2013 2014 2015 2016 2017 2018 2019 2020 CAGR

Lower Extremity Prosthetics 7,800.0 7,995.0 8,194.9 8,399.7 8,609.7 8,825.0 9,045.6 9,271.7 9,503.5 2.5%

% Growth 2.5% 2.5% 2.5% 2.5% 2.5% 2.5% 2.5% 2.5%

Upper Extremity Prosthetics 6,600.0 6,765.0 6,934.1 7,107.5 7,285.2 7,467.3 7,654.0 7,845.3 8,041.5 2.5%

% Growth 2.5% 2.5% 2.5% 2.5% 2.5% 2.5% 2.5% 2.5%

Source: GlobalData

Lower Extremity Prosthetics unit ASP is expected to increase from $7,800.0 in 2012 to $9,503.5 in 2020 with a CAGR

of 2.5%.

SAMPLE



Page 14

3.6 Orthopedic Prosthetics Market, United Kingdom, Distribution Share by Revenue ($m), 2011-2012

Table 7: Orthopedic Prosthetics Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2011-2012

Channel Name 2011 2012

Hospitals 42.2 44.1

Rehabilitation Centers 2.2 2.3

Acute Care Centers - -

Clinics - -

Drug Stores - -

Laboratories - -

Long Term Care Centers - -

Others - -

Source: GlobalData

"Hospitals" are the largest distribution channel for Orthopedic Prosthetics in United Kingdom with a 95.0% share of

the revenues.

SAMPLE



Page 15

3.7 Orthopedic Prosthetics Market, United Kingdom, Company Share by Revenue ($m), 2011-2012

Figure 5: Orthopedic Prosthetics Market, United Kingdom, Company Share (%), 2012

Note: Company Share estimates are based on company reports, secondary research and primary research

Source: GlobalData

Table 8: Orthopedic Prosthetics Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2011-2012

Company Name 2011 2012

Otto Bock HealthCare GmbH 18.6 19.7

Ossur hf. 8.7 9.3

The Ohio Willow Wood Company 1.2 1.3

Touch Bionics Limited 0.8 0.9

Others 15.1 15.2

Total 44.4 46.4

Source: GlobalData

Otto Bock HealthCare GmbH and Ossur hf. are the leading companies in the Orthopedic Prosthetics market in United

Kingdom with a combined share of 62.5%. In 2012, Otto Bock HealthCare GmbH led the Orthopedic Prosthetics

market with a 42.5% share, followed by Ossur hf. with 20.0%.

42.5%

20.0%

2.8%

1.9%

32.8%

Otto Bock HealthCare GmbH Ossur hf.

The Ohio Willow Wood Company Touch Bionics Limited

Others

SAMPLE



Page 16

4 Overview of Key Companies in United Kingdom Orthopedic Prosthetics Market

4.1 Otto Bock HealthCare GmbH

4.1.1 Company Overview

Otto Bock HealthCare GmbH (Otto Bock) is a medical device company. It is a group company of Otto Bock Holding

GmbH & Co. KG. The company manufactures and distributes prosthetic and orthotic devices. It also offers mobility

and seating devices for disabled adults and children. The product portfolio of the company includes prosthetic

products, mobility solutions, support and soft orthoses, and other related materials. Otto Bock carries out its business

in five business units: Prosthetics, Orthotics, Mobility Solutions, Neurostimulation and MedicalCare. The company,

along with its subsidiaries, operates in Europe, Asia-Pacific, Americas and Africa. Otto Bock is headquartered in

Duderstadt, Germany.

Otto Bock seeks to maintain its market leading position through the development of innovative disability products and

enhancement of existing ones, internal development, strong partner relationships and strategic acquisitions. In line

with its strategy, the company decided to acquire 51% of the shares of Pohlig GmbH.

4.2 Ossur hf.


Ossur hf. (Ossur) is a global orthopedic devices company. It undertakes the development, manufacture and sale of

prosthetics, bracing and support, and compression therapy products. The company develops its products with focus

on clinical outcomes and provides them with scientifically proven designs. Ossur is specialized in providing non-

invasive orthopedics. The company‟s research and development (R&D) activities focus on developing new products

that cater to the changing needs of its customers. It operates offices and manufacturing facilities across the US,

Canada, Mexico, the Netherlands, the UK, Spain, Germany, Sweden, Italy, France, South Africa, China, Australia,

Korea, Japan and Australia. The company is headquartered in Reykjavik, Iceland.

Ossur envisages on building its brand image in the marketplace through business expansion initiatives, such as

acquisitions and opening new branch offices. In line with this strategy, the company recently entered into an

agreement to acquire Teamolmed, opened Ossur Korea and a new manufacturing facility in Mexico.

The company reported revenues of (U.S. Dollars) USD 399.44 million during the fiscal year ended December 2012,

an increase of 0.28% over 2011. The operating profit of the company was USD 56.78 million during the fiscal year

2012, a decrease of 4.42% from 2011. The net profit of the company was USD 38.45 million during the fiscal year

2012, an increase of 13.73% over 2011.

4.3 The Ohio Willow Wood Company


The Ohio Willow Wood Company is an orthopedic device company. It designs and manufactures prosthetic products,

and components for artificial leg. The company is headquartered in Mt. Sterling, Ohio, the US.

SAMPLE



Page 17

4.4 Touch Bionics Limited


Touch Bionics Limited (Touch Bionics) is a healthcare service provider. The company provides prosthetic

technologies and supporting services designed for people suffering from upper limb deficiencies. Its products include

i-limb ultra, i-limb digits and livingskin. The product, I-limb ultra is powered prosthetic hand solution, i-limb digits is

customized electronic prosthesis for people with missing fingers or partial hands and livingskin is high definition

silicone and hand painted to match the skin color. The company offers Touch Care, a product support program to

enhance the user experience with the company products. It is a subsidiary company of Touch Bionics, Inc. Touch

Bionics is headquartered in Livingston, West Lothian, the UK.

SAMPLE



Page 18

5 Orthopedic Prosthetics Market Pipeline Products

Table 9: Orthopedic Prosthetics Market Pipeline Products

Product Name Company/University Name Equipment Type Territory

Computer-Controlled Prosthetic Scott Sabolich, Inc. Orthopedic Prosthetics Global

Durable Finger Prosthesis Trinity College Dublin Orthopedic Prosthetics Global

Implantable Robotic Arm Chalmers University of Technology Orthopedic Prosthetics Global

iWalk - PowerFoot One Simbex Orthopedic Prosthetics Global

Mind Controlled Robotic Arm University of Pittsburgh Orthopedic Prosthetics Global

Next Generation Prosthetic Limb The Florida State University Orthopedic Prosthetics Global

Sensory Feedback System Scott Sabolich, Inc. Orthopedic Prosthetics Global

Source: GlobalData

SAMPLE



Page 19

6 Financial Deals Landscape

6.1 Partnerships

6.1.1 Ergoresearch Enters Into Distribution Agreement With Proteor For Orthopedic Components

Table 10: Ergoresearch Enters Into Distribution Agreement With Proteor For Orthopedic Components

Deal Type Partnerships Deal Sub Type Co-Marketing

Deal in Brief

Ergoresearch Ltd., a manufacturer and provider of custom foot orthotics, prosthetics and medical equipment, entered into an agreement with

Proteor, a medical device company, for the purchase and distribution of components patented worldwide. The agreement provides exclusive

distribution rights across Canada. These components are used to manufacture and develop new devices dedicated to the orthopedics market,

specifically to the musculoskeletal system.

The agreement enables Ergoresearch and Proteor to improve their product offerings to patients.

Sylvain Boucher, president and CEO of Ergoresearch, said, "This agreement fits perfectly into the firm's strategic plan, given its intention to invest

heavily in the development of these components and in their clinical validation, which have met every aspect of our firm's quality and reliability

standards so far."

Michel Pierron, president of Proteor, said, "This agreement represents a very promising edge on the eventual breakthrough we expect this product

will have on the North-American market. The quality of this innovative device and the merit of its clinical validations have far surpassed our

expectations and when associated with the competence of Ergoresearch's teams of clinicians, it can only provide our patients with relief, and extra

comfort in their daily life."

Deal Rationale

The agreement enables Ergoresearch and Proteor to improve their product offerings to patients.

Deal Information

Deal Status Completed

Completed Date Aug 08, 2012

Companies Information

Partner Company Information

Company Name Proteor

Business Description

SAMPLE



Page 20

Proteor is a medical device manufacturer. The company design, manufacture and sells orthopaedic appliances for individuals with definitive

disabilities. It offers environmental control units, infrared phones, communication devices, and accessories and switches. Proteor provides

components, materials and equipment for professionals in the orthopaedic field. The company develops electronic assistive devices which helps

disabled people to communicate. It offers orthopedic appliances such as custom-made and mass-produced prostheses and orthoses. The

company serves patients, prosthetists, and orthotists and healthcare professionals. It has its presence in China, France, Vietnam and Czech

Republic. The company is a subsidiary of Holding Proteor S.A. Proteor is headquartered in St Apollinaire, Rhone Alpes, France.

Company Name Ergoresearch Ltd.

Business Description

Ergoresearch Ltd. (Ergoresearch) is a medical equipment company. The company develops and distributes orthopedic products. Ergoresearch‟s

products include brace patented distraction odra, 3D foot orthotics, barometric sensor mat in foot, and scanners. The company ‟s brace patented

distraction odra improves knee mobility by decreasing the intra articular pressure; barometric sensor mat in foot has a network of 7680 touch

sensors. Ergoresearch offers scanners for foot analysis. It provides products and solutions for the joint problems related to aging, diabetes, and

obesity, among others. The company‟s subsidiaries include Ortho Concept, Clinique du pied EQUILIBRE, and Langelier. Ergoresearch is

headquartered in Laval, Quebec, Canada.

Source: GlobalData

SAMPLE



Page 21

7 Recent Developments

7.1 Product News

7.1.1 Jul 08, 2013: Southampton engineers develop novel method to increase lifespan of joint replacements

Researchers at the University of Southampton have completed a project that will enable surgeons to fit joint

replacements with longer, optimised lifespans. The MXL project uses computational modelling to define the

mechanics of an artificial joint – a complex interaction of individual anatomy, prosthesis design, sizing and placement

– to ensure successful surgery and longer lifespans of the prosthetic joints.

Professor Markus Heller, leader of the MXL project, says: “Joint replacement surgery substitutes worn-out joint

tissues with artificial components. These artificial components will also fail eventually, some after only a few years,

with nearly ten per cent of all joint replacement operations in the EU each year taking place to replace prosthetics that

have worn out.

These „revisions‟ of joint replacement surgery are complex, require a longer rehabilitation and also come at a

substantial cost, with a hip revision estimated to cost €80,000.”

Surgeons today have to rely on their experience to best perform the joint replacement surgery to ensure long-lasting

function. There are currently no solutions to support their decision process by reliable, quantitative information on the

expected joint mechanics and functional outcome.

The ICT systems created by the MXL project, funded by the European Commission‟s Seventh Framework

Programme, will enable cost-effective development of robust prosthesis designs. It will also support surgical decision-

making to provide a safer route to optimal, functional outcome of joint surgery, independent of the surgeon‟s prior

experience and training.

Professor Heller says: “We developed a 3D musculoskeletal model, with data on the variations in bone shape and

tissue density, which has enabled advanced biomechanical assessment of the joint reconstruction. The development

of this specialised software allows the automated positioning of implants and allows us to modify implant size and

position, to address individual patient needs. The intention is, that this technology will lead to increased patient safety

and improved lifespan of joint replacement prosthetics.”

The MXL project consortium is now offering this unique technology to interested partners, in order to ensure that the

ground-breaking developments are transformed into tangible benefits.

SAMPLE



Page 22

8 Appendix

The data and analysis within this report is driven by Medical eTrack

Medical eTrack gives you the key information to drive sales, investment and deal making activity in your

business. It includes the following information:

15,000+ Market size data tables across more than 780 medical equipment segments and 15 countries with

historic data from 2005 forecast to 2020

6,000+ Primary expert interviews conducted per annum for ensuring data and report quality

1,100+ Conferences on medical equipment covered

1,000+ Industry leading reports per annum covering growing sectors, market trends, investment opportunities

and competitive landscape

600+ Analysis reports covering market and pipeline product analysis reports by indication, medical equipment

trends and issue reports and investment and M&A trend reports worth over $3 Million

50,000+ Medical equipment companies profiled

2,000+ Private, emerging and technology start-up company profiles

4,000+ Medical equipment manufacturers in China and India

2,000+ Medical equipment companies in Japan

825+ Companies with revenue splits and market shares by category

1,100+ Quarterly and annual medical equipment company financials

700+ Medical equipment company SWOT‟s

11,700+ Pipeline product profiles

14,000+ Marketed product profiles

16,900+ Clinical trials

17,000+ Trial investigators

18,000+ New product patents

3,700+ Companies with products in development

21,500+ Deals in the medical equipment industry

1,300+ Surgical and diagnostic procedures by therapy area

50+ Key healthcare indicators by country

For more information or to receive a free demo of the service, please visit

http://www.medicaletrack.com/ContactUs.aspx?Id=RequestDemo

SAMPLE

http://www.medicaletrack.com/ContactUs.aspx?Id=RequestDemo%20



Page 23

8.1 Research Methodology

GlobalData‟s dedicated research and analysis teams consists of qualified professionals with experience in marketing,

market research, consulting background in the medical devices industry and advanced statistical expertise.

GlobalData adheres to the codes of practice of the European Pharmaceutical Marketing Association (EphMRA -

http://www.ephmra.org/).

All GlobalData databases are continuously updated and revised.

8.1.1 Coverage

The objective of updating GlobalData‟s coverage is to ensure that it represents the most up to date vision of the

industry possible.

Changes to the industry taxonomy are built on the basis of extensive research of companies, associations and

competitor sources.

Company coverage is based on three key factors: revenues, products and media attention, innovation and

market potential.

The estimated revenues of all major companies, including private and public, are gathered and used to

prioritize coverage.

GlobalData aims to cover all major news events and deals in the medical device industry, updated on a daily basis.

The coverage is further streamlined and strengthened with additional inputs from GlobalData‟s expert panel.

8.1.2 Secondary Research

The research process begins with the exhaustive secondary research on the internal and external sources being

carried out to gather all relevant data and information pertaining to a particular market model for a particular country.

The secondary research sources that are typically referred to include, but are not limited to:

Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings;

Industry trade journals, scientific journals and other technical literature;

Association and healthcare organization websites;

Pubmed, Medscape and other related websites offering exhaustive review of clinical literature

Internal and external proprietary databases;

Relevant patent and regulatory databases;

National government documents, statistical databases and market reports;

Procedure registries; and

News articles, press releases and web-casts specific to the companies operating in the market.

SAMPLE

http://www.ephmra.org/



Page 24

8.1.3 Primary Research

GlobalData conducts interviews with industry participants and commentators in order to validate its data and analysis.

A typical research interview fulfills the following functions:

It provides first-hand information on market size, market trends, growth trends, competitive landscape and

future outlook;

Helps in validating and strengthening the secondary research findings; and

Further develops the analysis team‟s expertise and market understanding.

Primary research involves e-mail interactions and telephonic interviews for each market, category, segment

and sub-segment across geographies.

The participants who typically take part in such a process include, but are not limited to:

o Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers;

o Hospital stores, laboratories, pharmacies, distributors and paramedics;

o Outside experts: investment bankers, valuation experts, research analysts specializing in specific medical equipment markets; and

o Key opinion leaders: physicians and surgeons specializing in different therapeutic areas corresponding to different kinds of medical devices and equipment.

The market data was validated based on the inputs from 1,200 primary research participants. The primary research

participants included stakeholders from demand side such as the orthopedic surgeons, as well as participants from

the supply side such as the marketing managers, sales managers and product managers of companies

manufacturing/marketing orthopedic devices.

SAMPLE



Page 25

Table 11: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

Country Total Number of Primary Research Participants

United States 80

United Kingdom 104

Germany 83

France 86

Italy 85

Spain 75

Brazil 80

China 90

India 112

Russia 64

Japan 74

Australia 71

Canada 66

Mexico 64

South Korea 66

Total 1,200

Source: GlobalData

7.1.4 Market Modeling and Forecasting

GlobalData uses epidemiology-based treatment flow model and capital equipment based model to estimate and

forecast the market size.

Epidemiology-Based Market Models and Forecasting

Epidemiology based forecasting model makes use of epidemiology data gathered from research publications and

primary interviews with physicians to establish the target patient population and treatment flow patterns for individual

diseases and therapies. The epidemiology-based forecasting model considers the data on prevalence, incidence, and

diseased population, diagnosed and treated population.

The market forecast begins with the general population. This may vary depending upon the indication.

The prevalence of a disease is the percentage of the total population who suffer from a disease/condition.

Incidence is the number of new cases of a condition, symptom, death, or injury that develop during a specific

time period, such as a year.

The diagnosed population is the population diagnosed with a disease expressed as a percentage of the

prevalent population.

The treated population is calculated as a percentage of the population diagnosed with a disease.

SAMPLE



Page 26

The device uptake percentage is allocated based on the primary responses and the information available in

secondary sources.

The epidemiology-based forecasting model for a medical device is helpful in:

Deriving the type of patient segment which is actually going in for the use of specific devices and procedures.

Frequency of usage of the device depending on the patient type which further helps to arrive at the absolute

unit sale of a device in a year.

The market for any medical device is directly proportional to the volume of units sold and the price per unit.

Market Size = Volumes of units sold X Average Selling Price

The volume of units sold is calculated based on the number of patients implanted or using the device. Data on

treatment rate, diagnosis and surgical treatment rate, if unavailable from research publications, are gathered from

interviews with physicians and are used to estimate the patient volumes for the disease under consideration.

Average selling price (ASP) of the device is mostly gathered from primary and secondary sources. ASP is the price at

which a device is available in a target country to an end user (end user is defined in different ways for different nodes.

Eg: Typically for capital equipment, end user is considered to be the healthcare setting. For consumables purchased

by patient and implants, the end user is a patient).

Factors such as company share, reimbursement, company type (local/domestic or multinational) are taken into

consideration during analysis of average selling prices.

Following sources are used for ASP analysis:

Company websites

Annual reports/industry reports

Press releases

SAMPLE



Page 27

Epidemiology Based Forecasting Model

Capital Equipment Based Market Models and Forecasting

Capital equipment based forecasting models are done based on the installed based, replacements and new sales of

a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average

number of units per facility is used to arrive at installed base of the capital equipment. Sales for a particular year are

arrived at by calculating the replacement units and new units (additional and first time purchases). Secondary sources

and interviews with KOLs from healthcare facilities and supply side participants are used to arrive at installed base

and unit sales for a particular year. Factors typically affecting the forecast growth rates are:

Growth in the number of healthcare facilities

Healthcare spending and government programs and initiatives

Migration from low end equipment to high end equipment

Growth in the patient population undergoing diagnosis and treatment

Figure 6: GlobalData Epidemiology Based Forecasting Model

Source: GlobalData

SAMPLE



Page 28

Capital Equipment Based Forecasting Model

8.1.5 Company Share Analysis

Company shares are calculated by analyzing the company‟s sales in a particular market. In case of public companies,

annual reports and regulatory filings, investor presentations, earning call transcripts and broker reports are

extensively used for arriving at company revenue in a particular market for a particular geography.

In case of the private companies company share data is gathered mostly from the primary interviews and secondary

sources. Company share analysis is based on primary interviews from:

Supply side (Manufacturers)

o Procurement side

o Distributors

Hospital purchasing groups

Demand side (Surgeons/ Specialists)

The benefits of this approach are:

More number of respondents to validate and derive accurate company shares

Broader view from supply, demand, and procurement side

Figure 7: GlobalData Capital Equipment Based Forecasting Model

Source: GlobalData

SAMPLE



Page 29

50%

25%

25%

Procurement Side Supply Side Demand Side

To avoid biased opinion from any of the industry/market experts

The demand side interviews will help to understand KOLs preference for a device from a specific company

which strengthens the company share estimates

Primary Calls Split by Participants

Figure 8: Primary Calls Split by Participants

The final company shares data is based on inputs from; supply side, procurement side, and demand side as well as

secondary sources.

8.1.6 Distribution Share Analysis

Distribution share information is also gathered using a combination of secondary and primary research. Distribution

shares information is supported by primary interviews as availability of secondary data is limited in most cases.

8.2 Expert Panels

GlobalData uses a panel of experts to cross-verify its databases and forecasts.

GlobalData‟s expert panel comprises marketing managers, product specialists, international sales managers from

medical device companies; academics from research universities, KOLs from hospitals, consultants from venture

capital funds and distributors/suppliers of medical equipment and supplies etc.

Historic data and forecasts are relayed to GlobalData‟s expert panel for feedback and adjusted in accordance with

their feedback.

SAMPLE



Page 30

8.3 GlobalData Consulting

We hope that the data and analysis in this brief will help you make informed and imaginative business decisions. If

you have further requirements, GlobalData‟s consulting team may be able to help you. GlobalData offers tailor-made

analytical and advisory services to drive your key strategic decisions

8.5 Disclaimer

All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means,

electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher,

GlobalData.

SAMPLE

Documents

GDMECC0024DB · 5 Orthopedic Prosthetics Market Pipeline Products ... Orthopedic Devices Market, by Country ... Medical Equipment Market Reports are the ideal guide for anyone wishing